Nitric oxide regulates actin reorganization through cGMP and Ca2+/calmodulin in RAW 264.7 cells

被引:41
作者
Ke, XC [1 ]
Terashima, M [1 ]
Nariai, Y [1 ]
Nakashima, Y [1 ]
Nabika, T [1 ]
Tanigawa, Y [1 ]
机构
[1] Shimane Med Univ, Dept Biochem, Izumo, Shimane 6938501, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2001年 / 1539卷 / 1-2期
关键词
nitric oxide; actin; macrophage; (+/-)-(E)-2-[(E)-hydroxyimino]-6-methoxy-4-methyl-5-nitro-3-hexenamide; guanosine 3 ': 5 '-cyclic monophosphate;
D O I
10.1016/S0167-4889(01)00090-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) has been reported to be involved in the regulation of pseudopodia formation, phagocytosis and adhesion in macrophages through the reorganization of actin. In the present study, we directly separated the globular (G) and filamentous (F) actin from quiescent or NO-stimulated macrophage-like cell line RAW 264.7 cells in order to investigate the dynamic redistribution of actin pools. We also focused on the regulatory mechanisms of actin assembly, induced by NO and its possible subsequent signaling pathway. We showed that predominant G-actin coexisted with Triton X-100-insoluble filamentous (TIF) and Triton X-100-soluble filamentous actin in resting RAW 264.7 cells. The exogenous NO produced by (+/-)-(E)-2-[(E)-hydroxyimino]-6-methoxy-4-methyl-5-nitro-3-hexenamide (NOR1), the endogenous NO induced by lipopolysaccharide (LPS) plus interferon-gamma (IFN gamma), and dibutyryl-cGMP increased the contents of TIF-actin in dose- and time-dependent manners and altered its morphology. The increase in the TIF-actin contents induced by NOR1 or LPS plus IFN gamma was efficiently blocked by the radical scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide and the soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one or the arginine analogue N-G-monomethyl-L-arginine acetate, respectively. Preincubation with the calmodulin antagonist W-7 almost completely blocked the NO-induced TIF-actin increase and morphological change. On the other hand, preincubation with C3 transferase, an inhibitor of Rho protein, efficiently prevented the change in cell morphology, but had no effect on the TIF-actin increase. We postulate that cGMP and subsequent Ca2+/calmodulin may be key regulators of actin reorganization in NO-stimulated RAW 264.7 cells. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 113
页数:13
相关论文
共 42 条
[1]   NITRIC-OXIDE GENERATION FROM NITROPRUSSIDE BY VASCULAR TISSUE - EVIDENCE THAT REDUCTION OF THE NITROPRUSSIDE ANION AND CYANIDE LOSS ARE REQUIRED [J].
BATES, JN ;
BAKER, MT ;
GUERRA, R ;
HARRISON, DG .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 :S157-S165
[2]   Roles of nitric oxide in brain hypoxia-ischemia [J].
Bolaños, JP ;
Almeida, A .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :415-436
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   NITRIC-OXIDE - A PHYSIOLOGICAL MESSENGER MOLECULE [J].
BREDT, DS ;
SNYDER, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :175-195
[5]   Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis [J].
Clementi, E .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) :713-718
[6]   Guanylate cyclase and the .NO/cGMP signaling pathway [J].
Denninger, JW ;
Marletta, MA .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :334-350
[7]   Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells:: correlation with nitric oxide production [J].
Ferrero, R ;
Rodríguez-Pascual, F ;
Miras-Portugal, MT ;
Torres, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) :779-787
[8]   Fcγ receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn [J].
Fitzer-Attas, CJ ;
Lowry, M ;
Crowley, MT ;
Finn, AJ ;
Meng, FY ;
DeFranco, AL ;
Lowell, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :669-681
[9]   Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide [J].
Gidday, JM ;
Park, TS ;
Shah, AR ;
Gonzales, ER .
STROKE, 1998, 29 (07) :1423-1429
[10]  
GIRTH OW, 1996, METHOD ENZYMOL, V268, P375